Australian molecular diagnostics firm Genetic Signatures announced a strategic partnership with automation provider Tecan and IVD software developer Repado to create fully integrated syndromic infectious disease testing platforms. The collaboration combines Tecan's liquid handling technology, Repado's regulatory-compliant software, and Genetic Signatures’ panels targeting respiratory, gastrointestinal, and sexually transmitted infections. The integrated system aims to streamline workflows, ensure quality assurance and support lab scaling. Genetic Signatures plans to expand its syndromic test menu alongside this platform.